欧洲神经调节市场到 2027 年的预测 - COVID-19 影响和区域技术分析（外部（非侵入性）神经调节和内部神经调节）；应用（慢性疼痛管理、腰背综合症、癫痫、震颤、失禁、抑郁症、肌张力障碍、胃轻瘫、帕金森病、强迫症和偏头痛）；最终用户（医院、诊所和家庭医疗保健）
No. of Pages: 117 | Report Code: TIPRE00016296 | Category: Life Sciences
No. of Pages: 117 | Report Code: TIPRE00016296 | Category: Life Sciences
神经调节是通过控制神经递质的生理水平来调节神经活动的过程。这些改变是在各种设备的帮助下或通过药物输注实现的。这些设备包含放置在脊髓、大脑或周围神经上的小电极。脑血管疾病、阿尔茨海默病和帕金森病等神经系统疾病会影响身体的神经功能，因此可以借助神经调节进行治疗。
预计到 2027 年，欧洲神经调节市场将从 22.9633 亿美元增至 47.4175 亿美元。 2019；预计 2020 年至 2027 年复合年增长率为 9.8%。欧洲神经调节市场的增长归因于神经系统疾病发病率的增加以及神经调节技术的不断发展。然而，神经调节设备的高成本促进了该地区市场的增长。导致限制市场的增长。
根据技术，欧洲神经调节市场被细分分为外部（非侵入性）神经调节和内部神经调节。 2019年，内部神经调节领域占据了更大的市场份额。外部（非侵入性）神经调节预计在预测期内将以更快的速度增长。
在准备欧洲神经调节市场报告时提到的一些主要主要和次要来源包括世界卫生组织、卫生和预防部以及卫生和家庭福利部。 span>
雅培、波士顿科学公司、美敦力、NeuroPace, Inc.、NeuroSigma, Inc.、NEVRO CORP、Synapse Biomedical Inc.、Soterix Medical Inc、Integer Holdings Corporation 和 Magstim。
按技术划分
按应用
最终用户
按国家/地区
按国家/地区
Strategic insights for Europe Neuromodulation involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 2,296.33 Million |
| Market Size by 2027 | US$ 4,741.75 Million |
| Global CAGR (2020 - 2027) | 9.8% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By 技术
|
| Regions and Countries Covered | 欧洲
|
| Market leaders and key company profiles |
The regional scope of Europe Neuromodulation refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The List of Companies - Europe Neuromodulation Market
The Europe Neuromodulation Market is valued at US$ 2,296.33 Million in 2019, it is projected to reach US$ 4,741.75 Million by 2027.
As per our report Europe Neuromodulation Market, the market size is valued at US$ 2,296.33 Million in 2019, projecting it to reach US$ 4,741.75 Million by 2027. This translates to a CAGR of approximately 9.8% during the forecast period.
The Europe Neuromodulation Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Neuromodulation Market report:
The Europe Neuromodulation Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Neuromodulation Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Neuromodulation Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Neuromodulation Market
